Reserpine-induced reduction in norepinephrine transporter function requires catecholamine storage vesicles

[1]  H. Sitte,et al.  Physical and Functional Interaction between the Dopamine Transporter and the Synaptic Vesicle Protein Synaptogyrin-3 , 2009, The Journal of Neuroscience.

[2]  N. Lambert,et al.  Activity‐dependent regulation of the dopamine transporter is mediated by Ca2+/calmodulin‐dependent protein kinase signaling , 2008, The European journal of neuroscience.

[3]  I. Sora,et al.  Genetic deletion of vesicular monoamine transporter-2 (VMAT2) reduces dopamine transporter activity in mesencephalic neurons in primary culture , 2007, Neurochemistry International.

[4]  G. Ordway,et al.  KCl stimulation increases norepinephrine transporter function in PC12 cells , 2006, Journal of neurochemistry.

[5]  G. Ordway,et al.  The norepinephrine transporter and its regulation , 2006, Journal of neurochemistry.

[6]  H. Bönisch,et al.  Functional importance of the C‐terminus of the human norepinephrine transporter , 2004, Journal of neurochemistry.

[7]  S. Ramamoorthy,et al.  Regulated Internalization and Phosphorylation of the Native Norepinephrine Transporter in Response to Phorbol Esters , 2004, Journal of Biological Chemistry.

[8]  D. Morilak,et al.  Regulation of the norepinephrine transporter by chronic administration of antidepressants , 2004, Biological Psychiatry.

[9]  H. Bönisch,et al.  The neuronal noradrenaline transport system of PC-12 cells: Kinetic analysis of the interaction between noradrenaline, Na+ and Cl− in transport , 1986, Naunyn-Schmiedeberg's Archives of Pharmacology.

[10]  G. Miller,et al.  Inhibitory effect of reserpine on dopamine transporter function. , 2002, European journal of pharmacology.

[11]  R. Blakely,et al.  Monoamine transporter gene structure and polymorphisms in relation to psychiatric and other complex disorders , 2002, The Pharmacogenomics Journal.

[12]  R. Blakely,et al.  Trafficking-dependent and -independent pathways of neurotransmitter transporter regulation differentially involving p38 mitogen-activated protein kinase revealed in studies of insulin modulation of norepinephrine transport in SK-N-SH cells. , 2001, The Journal of pharmacology and experimental therapeutics.

[13]  H. Bönisch,et al.  Effects of short- and long-term exposure to c-AMP and c-GMP on the noradrenaline transporter , 2001, Neuropharmacology.

[14]  Fei Xu,et al.  Mice lacking the norepinephrine transporter are supersensitive to psychostimulants , 2000, Nature Neuroscience.

[15]  R. Wightman,et al.  Vesicular Ca2+ Participates in the Catalysis of Exocytosis* , 2000, The Journal of Biological Chemistry.

[16]  S. Cichon,et al.  Tourette syndrome and the norepinephrine transporter gene: results of a systematic mutation screening. , 1999, American journal of medical genetics.

[17]  Y. Kiuchi,et al.  Ca2+-dependent enhancement of [ 3 H ]noradrenaline uptake in PC12 cells through calmodulin-dependent kinases , 1998, Brain Research.

[18]  R. Blakely,et al.  Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins. , 1998, The Journal of pharmacology and experimental therapeutics.

[19]  H. C. Hartzell,et al.  Acute regulation of norepinephrine transport: I. protein kinase C-linked muscarinic receptors influence transport capacity and transporter density in SK-N-SH cells. , 1998, The Journal of pharmacology and experimental therapeutics.

[20]  G. H. Zhang,et al.  Alterations in Ca2+ storage and mobilization in submandibular acinar cells of reserpine-treated rats. , 1998, Comparative biochemistry and physiology. Part C, Pharmacology, toxicology & endocrinology.

[21]  内田 淳.  Ca[2+]-Dependent Enhancement of [3H]Noradrenaline Uptake in PC12 Cells through Calmodulin-Dependent Kinases , 1998 .

[22]  J. Henry,et al.  Molecular pharmacology of the vesicular monoamine transporter. , 1998, Advances in pharmacology.

[23]  H. Bönisch,et al.  Role of protein kinase C and second messengers in regulation of the norepinephrine transporter. , 1998, Advances in pharmacology.

[24]  H. Meltzer,et al.  Reduced Levels of Norepinephrine Transporters in the Locus Coeruleus in Major Depression , 1997, The Journal of Neuroscience.

[25]  G. Ordway,et al.  Down‐Regulation of Norepinephrine Transporters on PC12 Cells by Transporter Inhibitors , 1997, Journal of neurochemistry.

[26]  J. C. Stoof,et al.  Glutathione Is Involved in the Granular Storage of Dopamine in Rat PC12 Pheochromocytoma Cells: Implications for the Pathogenesis of Parkinson’s Disease , 1996, The Journal of Neuroscience.

[27]  A. Laslop,et al.  Processing of chromogranins in chromaffin cell culture: effects of reserpine and alpha-methyl-p-tyrosine. , 1996, The Biochemical journal.

[28]  G. Richardt,et al.  Upregulation of cardiac uptake 1 carrier in ischemic and nonischemic rat heart. , 1996, Circulation research.

[29]  S. Amara,et al.  Cell-type-specific expression of catecholamine transporters in the rat brain , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[30]  V. Ganapathy,et al.  Calmodulin-dependent regulation of the catalytic function of the human serotonin transporter in placental choriocarcinoma cells. , 1994, The Journal of biological chemistry.

[31]  L. Smets,et al.  Extragranular storage of the neuron blocking agent meta-iodobenzylguanidine (MIBG) in human neuroblastoma cells. , 1990, Biochemical pharmacology.

[32]  L. Smets,et al.  Active uptake and extravesicular storage of m-iodobenzylguanidine in human neuroblastoma SK-N-SH cells. , 1989, Cancer research.

[33]  M. Roisin,et al.  Molecular Pharmacology of the Monoamine Transporter of the Chromaffin Granule Membrane a , 1987, Annals of the New York Academy of Sciences.

[34]  W. Sadee,et al.  Human neuroblastoma cell lines as models of catechol uptake , 1986, Brain Research.

[35]  J. A. Wagner,et al.  Structure of Catecholamine Secretory Vesicles from PC12 Cells , 1985, Journal of neurochemistry.

[36]  J. Javitch,et al.  Recognition sites for norepinephrine uptake: regulation by neurotransmitter. , 1983, Science.

[37]  A. Weber,et al.  Uptake of Nucleotides and Catecholamines by Chromaffin Granules from Pig and Horse Adrenal Medulla , 1980, Journal of neurochemistry.

[38]  S. Schuldiner,et al.  Reserpine as a competitive and reversible inhibitor of the catecholamine transporter of bovine chromaffin granules , 1979, FEBS letters.

[39]  L S Freedman,et al.  Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. , 1978, Cancer research.

[40]  T. Slotkin,et al.  Effects of reserpine on the content and properties of rat adrenal medullary storage vesicles. , 1973, Biochemical pharmacology.

[41]  N. Kirshner.  Uptake of Catecholamines by a Particulate Fraction of the Adrenal Medulla , 1962, Science.